212 related articles for article (PubMed ID: 11602735)
1. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.
Chien PC; Cohen S; Tuen M; Arthos J; Chen PD; Patel S; Hioe CE
J Virol; 2004 Jul; 78(14):7645-52. PubMed ID: 15220439
[TBL] [Abstract][Full Text] [Related]
4. High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression.
Chien PC; Cohen S; Kleeberger C; Giorgi J; Phair J; Zolla-Pazner S; Hioe CE
J Infect Dis; 2002 Jul; 186(2):205-13. PubMed ID: 12134256
[TBL] [Abstract][Full Text] [Related]
5. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
[TBL] [Abstract][Full Text] [Related]
7. Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies.
Laal S; Burda S; Gorny MK; Karwowska S; Buchbinder A; Zolla-Pazner S
J Virol; 1994 Jun; 68(6):4001-8. PubMed ID: 7514683
[TBL] [Abstract][Full Text] [Related]
8. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
[TBL] [Abstract][Full Text] [Related]
9. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
10. Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1.
Hioe CE; Hildreth JE; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):523-31. PubMed ID: 10221529
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120.
Jeffs SA; Gorny MK; Williams C; Revesz K; Volsky B; Burda S; Wang XH; Bandres J; Zolla-Pazner S; Holmes H
Immunol Lett; 2001 Dec; 79(3):209-13. PubMed ID: 11600200
[TBL] [Abstract][Full Text] [Related]
12. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
13. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
15. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
[TBL] [Abstract][Full Text] [Related]
16. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
[TBL] [Abstract][Full Text] [Related]
17. Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins.
Gorny MK; VanCott TC; Williams C; Revesz K; Zolla-Pazner S
Virology; 2000 Feb; 267(2):220-8. PubMed ID: 10662617
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HSV-1-specific cytotoxic T lymphocytes by recombinant-derived gp120 of HIV-1.
Schmid DS; Thieme ML; Ridgeway MR; Mawle AC
Viral Immunol; 1992; 5(4):249-56. PubMed ID: 1361737
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site.
McKeating JA; Moore JP; Ferguson M; Marsden HS; Graham S; Almond JW; Evans DJ; Weiss RA
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):451-9. PubMed ID: 1376134
[TBL] [Abstract][Full Text] [Related]
20. Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein.
Walker L; Wilks D; O'Brien J; Habeshaw J; Dalgleish A
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1083-90. PubMed ID: 1503822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
